电磁兼容性和无线电频谱管理（ERM）；短程设备（SRD）；感应线圈系统参考文件-超低功率有源医用植入物（ULP-AMI）-在9 kHz至315 kHz频带内运行的系统本文件适用于 短距离设备（SRD）发射机和接收机系统领域，这些发射机和接收机系统在不同频率下工作 范围为9 kHz至315 kHz。本文件给出了工作频率、分析和测试用发射机屏蔽的定义指南 从静止程序员或移动设备传输功率和数据的频谱要求 神经刺激系统（疼痛控制）与主动医疗植入物之间的连接。本文件考虑了ERC报告44[1]，并包含无线电设备的技术特征 如CEPT/ERC建议70-03[2]所述。因此，9 kHz至135 kHz的频率范围已被确定 CEPT/ERC建议70-03[2]中对感应系统进行了充分调节。必要的操作 CEPT/ERC建议70-03[2]中未提及135 kHz至315 kHz的频率范围，但在 提交文件。作为本文件主题的感应回路ULP-AMI设备的频谱参数旨在: 作为规范性附录包含在EN 300 330-2[3]或新的欧洲协调标准中。它们已提交 考虑将CEPT/ERC WGSE纳入合规性研究，并将其纳入WGFM/SRD MG纳入CEPT/ERC 建议70-03[2]，附件12。

Electromagnetic compatibility and Radio spectrum Matters (ERM); Short Range Devices (SRD); System Reference Document for inductive Loop - Ultra Low Power Active Medical Implants (ULP- AMI) - systems operating in the frequency bands 9 kHz to 315 kHzThe present document applies to the radio sections of inductive loop Ultra Low Power Active Medical Implants in the field of Short Range Devices (SRDs) transmitters and receiver systems operating on various frequencies within the range of 9 kHz to 315 kHz.The present document gives guidance on the definition of a transmitter mask for the operating frequencies, analyses and the spectrum requirements for transmission of power and data from/to stationary programmers or mobile neurostimulation systems (pain control) to/from active medical implants.The present document considers the ERC Report 44, [1] and contains the technical characteristics for radio equipment as given in CEPT/ERC Recommendation 70-03 [2]. Therefore, the frequency range 9 kHz to 135 kHz is already sufficiently regulated for inductive systems in CEPT/ERC Recommendation 70-03 [2]. The necessary operation for the frequency range 135 kHz to 315 kHz is not addressed in CEPT/ERC Recommendation 70-03 [2] and is addressed in the present document.The spectrum parameters for inductive loop ULP-AMI devices that are the subject of this document are intended to be included as a normative annex in the EN 300 330-2 [3] or in a new European Harmonized Standard. They are submitted for consideration to CEPT/ERC WGSE for compliance studies and in WGFM/SRD MG for inclusion in the CEPT/ERC Recommendation 70-03 [2], annex 12.